154 related articles for article (PubMed ID: 16497274)
1. Effects of nicotine vary across two auditory evoked potentials in the mouse.
Metzger KL; Maxwell CR; Liang Y; Siegel SJ
Biol Psychiatry; 2007 Jan; 61(1):23-30. PubMed ID: 16497274
[TBL] [Abstract][Full Text] [Related]
2. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
[TBL] [Abstract][Full Text] [Related]
3. Male and female mice differ for baseline and nicotine-induced event related potentials.
Amann LC; Phillips JM; Halene TB; Siegel SJ
Behav Neurosci; 2008 Oct; 122(5):982-90. PubMed ID: 18823155
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
Knott V; Millar A; Fisher D; Albert P
Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
[TBL] [Abstract][Full Text] [Related]
5. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
Radek RJ; Robb HM; Stevens KE; Gopalakrishnan M; Bitner RS
J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
[TBL] [Abstract][Full Text] [Related]
6. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
Simosky JK; Stevens KE; Adler LE; Freedman R
Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
[TBL] [Abstract][Full Text] [Related]
7. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
[TBL] [Abstract][Full Text] [Related]
8. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
Ehrlichman RS; Maxwell CR; Majumdar S; Siegel SJ
J Cogn Neurosci; 2008 Aug; 20(8):1403-14. PubMed ID: 18303985
[TBL] [Abstract][Full Text] [Related]
9. Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials.
Rudnick ND; Koehler C; Picciotto MR; Siegel SJ
Psychopharmacology (Berl); 2009 Mar; 202(4):745-51. PubMed ID: 18931833
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
Knott VJ; Fisher DJ; Millar AM
Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
[TBL] [Abstract][Full Text] [Related]
11. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
Phillips JM; Ehrlichman RS; Siegel SJ
Neuroscience; 2007 Feb; 144(4):1314-23. PubMed ID: 17184927
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials.
Baldeweg T; Wong D; Stephan KE
Int J Psychophysiol; 2006 Jan; 59(1):49-58. PubMed ID: 16313986
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
Kohlhaas KL; Robb HM; Roderwald VA; Rueter LE
Biochem Pharmacol; 2015 Oct; 97(4):482-487. PubMed ID: 26032639
[TBL] [Abstract][Full Text] [Related]
14. Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
Knott V; de la Salle S; Smith D; Phillipe T; Dort H; Choueiry J; Impey D
J Psychopharmacol; 2013 Sep; 27(9):790-800. PubMed ID: 23744798
[TBL] [Abstract][Full Text] [Related]
15. The effect of immobilization stress on sensory gating in mice.
Süer C; Dolu N; Ozesmi C
Int J Neurosci; 2004 Jan; 114(1):55-65. PubMed ID: 14660067
[TBL] [Abstract][Full Text] [Related]
16. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
[TBL] [Abstract][Full Text] [Related]
17. The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
Chan PY; Davenport PW
J Appl Physiol (1985); 2010 Mar; 108(3):662-9. PubMed ID: 20056851
[TBL] [Abstract][Full Text] [Related]
18. P50 sensory gating: impact of high vs. low schizotypal personality and smoking status.
Wan L; Crawford HJ; Boutros N
Int J Psychophysiol; 2006 Apr; 60(1):1-9. PubMed ID: 15955583
[TBL] [Abstract][Full Text] [Related]
19. The effect of smoking on pain-related evoked potentials.
Miyazaki T; Wang X; Inui K; Domino EF; Kakigi R
Brain Res; 2010 Feb; 1313():185-91. PubMed ID: 20025851
[TBL] [Abstract][Full Text] [Related]
20. Effects of cigarette smoking on cognitive processing.
Aşçioglu M; Dolu N; Gölgeli A; Süer C; Ozesmi C
Int J Neurosci; 2004 Mar; 114(3):381-90. PubMed ID: 14754662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]